Ameriprise Financial Inc Olink Holding Ab (Publ) Transaction History

Ameriprise Financial Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$14.45 - $20.34 $11,444 - $16,109	-792 Reduced 0.17%	468,173 $6.91 Million
Q2 2023 Aug 14, 2023	SELL	$17.13 - $23.74 $5.31 Million - $7.36 Million	-309,950 Reduced 39.79%	468,965 $8.79 Million
Q1 2023 May 15, 2023	BUY	$19.34 - $24.11 $149,459 - $186,322	7,728 Added 1.0%	778,915 $17.5 Million
Q4 2022 Feb 14, 2023	SELL	$12.64 - $25.52 $5,245 - $10,590	-415 Reduced 0.05%	771,187 $19.6 Million
Q3 2022 Nov 14, 2022	BUY	$12.14 - $18.42 $1.54 Million - $2.34 Million	127,074 Added 19.72%	771,602 $9.37 Million
Q2 2022 Aug 15, 2022	BUY	$8.95 - $19.24 $27,816 - $59,797	3,108 Added 0.48%	644,528 $9.8 Million
Q1 2022 May 16, 2022	SELL	$11.33 - $19.3 $610,788 - $1.04 Million	-53,909 Reduced 7.75%	641,420 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$18.0 - $34.82 $253,368 - $490,126	14,076 Added 2.07%	695,329 $12.7 Million
Q3 2021 Nov 15, 2021	BUY	$23.42 - $37.93 $6,042 - $9,785	258 Added 0.04%	681,253 $16.5 Million
Q2 2021 Aug 16, 2021	BUY	$26.65 - $39.47 $349,461 - $517,570	13,113 Added 1.96%	680,995 $23.4 Million
Q1 2021 May 17, 2021	BUY	$31.9 - $36.0 $21.3 Million - $24 Million	667,882 New	667,882 $24 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.